Utama › Kanser Anus › New York
Kajian klinikal Kanser Anus di New York
7 kajian untuk Kanser Anus sedang mencari peserta di lokasi di New York.
Bandar di New York
Teks kajian rasmi (Bahasa Inggeris)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New York Long Island LLC, Lake Success
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07217171A Study of IDP-001 in Advanced or Metastatic Solid Tumors
- Roswell Park Cancer Institute, Buffalo
- START New York Long Island, Lake Success
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07602842Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT05663502Adaptive Radiation in Anal Cancer
- Columbia University Irving Medical Center, New York
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Feb 2026 · NCT05838391Screening Women With Prior HPV for Anal Neoplasia
- Icahn School of Medicine at Mount Sinai, New York
Mengambil peserta
Umur 35 ke atas · Wanita · Dikemas kini 22 Ogo 2025 · NCT05217940Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.